151 related articles for article (PubMed ID: 35865740)
1. Efficacy of a 3% Kānuka oil cream for the treatment of moderate-to-severe eczema: A single blind randomised vehicle-controlled trial.
Shortt N; Martin A; Kerse K; Shortt G; Vakalalabure I; Barker L; Singer J; Black B; Liu A; Eathorne A; Weatherall M; Rademaker M; Armour M; Beasley R; Semprini A;
EClinicalMedicine; 2022 Sep; 51():101561. PubMed ID: 35865740
[TBL] [Abstract][Full Text] [Related]
2. Mānuka oil based ECMT-154 versus vehicle control for the topical treatment of eczema: study protocol for a randomised controlled trial in community pharmacies in Aotearoa New Zealand.
Shortt G; Shortt N; Bird G; Kerse K; Lieffering N; Martin A; Eathorne A; Black B; Kim B; Rademaker M; Reiche L; Paa ST; Harding S; Armour M; Semprini A
BMC Complement Med Ther; 2024 Jan; 24(1):61. PubMed ID: 38287323
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of lotion, cream, gel, and ointment emollients for childhood eczema: a pragmatic, randomised, phase 4, superiority trial.
Ridd MJ; Santer M; MacNeill SJ; Sanderson E; Wells S; Webb D; Banks J; Sutton E; Roberts A; Liddiard L; Wilkins Z; Clayton J; Garfield K; Barrett TJ; Lane JA; Baxter H; Howells L; Taylor J; Hay AD; Williams HC; Thomas KS
Lancet Child Adolesc Health; 2022 Aug; 6(8):522-532. PubMed ID: 35617974
[TBL] [Abstract][Full Text] [Related]
4. Emollient bath additives for the treatment of childhood eczema (BATHE): multicentre pragmatic parallel group randomised controlled trial of clinical and cost effectiveness.
Santer M; Ridd MJ; Francis NA; Stuart B; Rumsby K; Chorozoglou M; Becque T; Roberts A; Liddiard L; Nollett C; Hooper J; Prude M; Wood W; Thomas KS; Thomas-Jones E; Williams HC; Little P
BMJ; 2018 May; 361():k1332. PubMed ID: 29724749
[TBL] [Abstract][Full Text] [Related]
5. Adding emollient bath additives to standard eczema management for children with eczema: the BATHE RCT.
Santer M; Rumsby K; Ridd MJ; Francis NA; Stuart B; Chorozoglou M; Roberts A; Liddiard L; Nollett C; Hooper J; Prude M; Wood W; Thomas-Jones E; Becque T; Thomas KS; Williams HC; Little P
Health Technol Assess; 2018 Oct; 22(57):1-116. PubMed ID: 30362939
[TBL] [Abstract][Full Text] [Related]
6. A randomised placebo-controlled trial of oral and topical antibiotics for children with clinically infected eczema in the community: the ChildRen with Eczema, Antibiotic Management (CREAM) study.
Francis NA; Ridd MJ; Thomas-Jones E; Shepherd V; Butler CC; Hood K; Huang C; Addison K; Longo M; Marwick C; Wootton M; Howe R; Roberts A; Haq MI; Madhok V; Sullivan F;
Health Technol Assess; 2016 Mar; 20(19):i-xxiv, 1-84. PubMed ID: 26938214
[TBL] [Abstract][Full Text] [Related]
7. A multicentre randomised controlled trial and economic evaluation of ion-exchange water softeners for the treatment of eczema in children: the Softened Water Eczema Trial (SWET).
Thomas KS; Koller K; Dean T; O'Leary CJ; Sach TH; Frost A; Pallett I; Crook AM; Meredith S; Nunn AJ; Burrows N; Pollock I; Graham-Brown R; O'Toole E; Potter D; Williams HC
Health Technol Assess; 2011 Feb; 15(8):v-vi, 1-156. PubMed ID: 21324289
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Reich K; Teixeira HD; de Bruin-Weller M; Bieber T; Soong W; Kabashima K; Werfel T; Zeng J; Huang X; Hu X; Hendrickson BA; Ladizinski B; Chu AD; Silverberg JI
Lancet; 2021 Jun; 397(10290):2169-2181. PubMed ID: 34023009
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Simpson EL; Sinclair R; Forman S; Wollenberg A; Aschoff R; Cork M; Bieber T; Thyssen JP; Yosipovitch G; Flohr C; Magnolo N; Maari C; Feeney C; Biswas P; Tatulych S; Valdez H; Rojo R
Lancet; 2020 Jul; 396(10246):255-266. PubMed ID: 32711801
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
[TBL] [Abstract][Full Text] [Related]
11. Kanuka honey versus aciclovir for the topical treatment of herpes simplex labialis: a randomised controlled trial.
Semprini A; Singer J; Braithwaite I; Shortt N; Thayabaran D; McConnell M; Weatherall M; Beasley R
BMJ Open; 2019 May; 9(5):e026201. PubMed ID: 31092654
[TBL] [Abstract][Full Text] [Related]
12. Randomised controlled trial of silk therapeutic garments for the management of atopic eczema in children: the CLOTHES trial.
Thomas KS; Bradshaw LE; Sach TH; Cowdell F; Batchelor JM; Lawton S; Harrison EF; Haines RH; Ahmed A; Dean T; Burrows NP; Pollock I; Buckley HK; Williams HC; Llewellyn J; Crang C; Grundy JD; Guiness J; Gribbin A; Wake EV; Mitchell EJ; Brown SJ; Montgomery AA
Health Technol Assess; 2017 Apr; 21(16):1-260. PubMed ID: 28409557
[TBL] [Abstract][Full Text] [Related]
13. Interventions to reduce Staphylococcus aureus in the management of eczema.
George SM; Karanovic S; Harrison DA; Rani A; Birnie AJ; Bath-Hextall FJ; Ravenscroft JC; Williams HC
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684694
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial.
Lee LA; Bailes Z; Barnes N; Boulet LP; Edwards D; Fowler A; Hanania NA; Kerstjens HAM; Kerwin E; Nathan R; Oppenheimer J; Papi A; Pascoe S; Brusselle G; Peachey G; Sule N; Tabberer M; Pavord ID
Lancet Respir Med; 2021 Jan; 9(1):69-84. PubMed ID: 32918892
[TBL] [Abstract][Full Text] [Related]
15. Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial.
Rosmarin D; Pandya AG; Lebwohl M; Grimes P; Hamzavi I; Gottlieb AB; Butler K; Kuo F; Sun K; Ji T; Howell MD; Harris JE
Lancet; 2020 Jul; 396(10244):110-120. PubMed ID: 32653055
[TBL] [Abstract][Full Text] [Related]
16. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
Loncharich MF; Anderson CW
ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
[TBL] [Abstract][Full Text] [Related]
17. Randomised controlled trial of topical kanuka honey for the treatment of rosacea.
Braithwaite I; Hunt A; Riley J; Fingleton J; Kocks J; Corin A; Helm C; Sheahan D; Tofield C; Montgomery B; Holliday M; Weatherall M; Beasley R
BMJ Open; 2015 Jun; 5(6):e007651. PubMed ID: 26109117
[TBL] [Abstract][Full Text] [Related]
18. Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials.
Guttman-Yassky E; Teixeira HD; Simpson EL; Papp KA; Pangan AL; Blauvelt A; Thaçi D; Chu CY; Hong HC; Katoh N; Paller AS; Calimlim B; Gu Y; Hu X; Liu M; Yang Y; Liu J; Tenorio AR; Chu AD; Irvine AD
Lancet; 2021 Jun; 397(10290):2151-2168. PubMed ID: 34023008
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the effect of weekly patient-reported symptom monitoring on trial outcomes: results of the Eczema Monitoring Online randomized controlled trial.
Baker A; Mitchell EJ; Partlett C; Thomas KS
Br J Dermatol; 2023 Jul; 189(2):180-187. PubMed ID: 37194567
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
